- Dell Taking Further Steps To Cut Staff and Costs
- Marvel Posts Marvel-ous Profits, Sees Modest 2009
- Consumer Bankruptcies Soar in October
- Why the US Market Rallied Even Before Vote Was Over
- Fiscal Boost Needed to Lift Economy: Fed's Fisher
- World Closely Watching US Election
- GE Open to Using Bailout Money For Lending Arm
- Factory Orders Drop More than Expected
- Global Stocks Stage Rally As US Votes for President
- Oil: Fourth Biggest One-Day Gain Ever
- Investor Fear Dropping
- Election Day Long Lines Are For—Starbucks!
- Stop Trading!: Election Day Trading
- Intrade Political Futures: Will this election make the Senate Filibuster Proof?
- Big Pharma "Healthier" For Obama With Campaign Money
- Iron Man Drives Marvel's 40 Percent Earnings Growth
- More From McCain Headquarters: Will Palin Speak? (Yes)
- Accidental Dividends?
- D.R. Horton expects $800M-$900M loss in 4Q
- Boeing says 787 test flight delayed due to strike
- Unit Corp. shares rise on 3Q profit report
- PetroQuest 3rd-quarter profit more than doubles
- Columbia Sportswear cutting 75 jobs as orders slip
- Bomb explodes at Swedish hotel, 1 injured
- This year's Antarctic zone hole is 5th biggest
- Report: Drilling on federal lands could be faster
- Pinnacle West Capital profit falls 27 pct in 3Q
- Myriad Genetics hits high after solid 3Q results
NEW YORK - Shares in Johnson & Johnson fell 4.1 percent Wednesday after JPMorgan downgraded the stock, saying it is overvalued.
The stock slid $2.66 to close at $61.53. In the past year, it has ranged from $52.06 to $72.76.
Analyst Michael Weinstein cut his rating to "Neutral" from "Overweight." He said the stock is trading at a premium of more than 25 percent versus an evaluation of the value of the "sum of its parts."
That makes it a good time to stop accumulating shares, since historically they have underperformed the Standard & Poor's 500 index when that premium has been more than 5 percent, he wrote.
Weinstein said the stock has only once before traded at a premium of 15 percent to that metric, which attempts to put a value on each division.
He said J&J does deserve to be more expensive than its peers because its pipeline of products is deeper and growth is likely to be higher. But he said that premium is now "hyperbolic."



